GammaVibe Daily
The FDA's quiet shift to synthetic patients
A regulatory pivot is unlocking a multi-billion dollar shortcut for rare disease drug development. Meet Kohrt.
Software-as-a-Service recurring revenue models.
GammaVibe Daily
A regulatory pivot is unlocking a multi-billion dollar shortcut for rare disease drug development. Meet Kohrt.
GammaVibe Daily
Brain-computer interfaces are getting faster and more accurate. But how do we filter out our intrusive thoughts?
GammaVibe Daily
Enterprises are scrambling to escape massive VMware pricing hikes. Here is how Shyftr automates the transition to alternative hypervisors.
GammaVibe Daily
Traditional SEO is fading. Here is how brands are optimizing for Perplexity, Gemini, and ChatGPT.
GammaVibe Daily
How Terminus converts unstructured radio chatter into a live, visual map of shipping terminals.
GammaVibe Daily
With physical backlogs freezing millions in collector capital, computer vision is unlocking the secondary market.
GammaVibe Daily
Boutique hotels are sitting on goldmines of fragmented data. GuestMesh is the lightweight ETL pipeline designed to finally clean it up.
GammaVibe Daily
Runaway AI crawlers are hammering travel APIs with hundreds of thousands of queries per booking. Here is how Bramble is fighting back.
GammaVibe Daily
Valetudo is building the API-driven middleware that standardizes wellness tracker data into clinical-grade HL7 FHIR packets for direct EHR integration.
GammaVibe Daily
How Lichen is building a cryptographic trust layer for the booming, unverified peptide market.
GammaVibe Daily
How Nyx is bypassing the real estate oligopoly to unlock off-market inventory.
GammaVibe Daily
As AI agents generate millions of lines of code, Git is losing the "why." Here is how we build the database of coding intent.